Macleans
Osteoporosis Breakthrough
In the spring of 1997, William Boyle, a microbiologist at Amgen Inc., a drug company based near Los Angeles, placed a telephone call to Dr. Josef Penninger, an immunologist at the firm's Toronto offshoot, the Amgen Research Institute.This article was originally published in Maclean's Magazine on February 8, 1999